The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet‐refractory patients

The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet‐refractory patients

BACKGROUND Single antigen bead (SAB) assays are used to identify human leukocyte antigen (HLA) antibodies in patients with platelet refractoriness due to HLA Class I alloimmunization. Some laboratories use serum pretreatment regimens to eliminate interference from immunoglobulin M antibodies and com...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion (Philadelphia, Pa.) Vol. 60; no. 3; pp. 488 - 497
Main Authors: Tumer, Gizem, Gniadek, Thomas, Baye, Jennifer, Pena, Ryan, Warner, Paul, Fung, Mark, Beaudin, Lynette, Dunckley, Heather, Gandhi, Manish, Gathof, Birgit, Hsu, Susan, Klohe, Ellen, Marcus, Nalaja, Bamert, Roberta, Sims, Shona, Takanashi, Minoko, Wendel, Silvano, Cohn, Claudia S.
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-03-2020
Wiley Subscription Services, Inc
Subjects:
Acetic acid
Antibodies
Antigens
Coefficient of variation
Confidence intervals
Deactivation
Dithiothreitol
Fluorescence
Heat inactivation
Histocompatibility antigen HLA
Immunoglobulin M
Immunoglobulins
Inactivation
Inhibitors
Instrumentation
Interference
Isoimmunization
Laboratories
Leukocytes
Platelets
Thermal resistance
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Single antigen bead (SAB) assays are used to identify human leukocyte antigen (HLA) antibodies in patients with platelet refractoriness due to HLA Class I alloimmunization. Some laboratories use serum pretreatment regimens to eliminate interference from immunoglobulin M antibodies and complement. These modifications may contribute to interlaboratory variability, which is a recognized problem with the SAB assay. STUDY DESIGN AND METHODS Five patientsʼ sera were overnight shipped to 12 laboratories in the United States and internationally. Recipients used their labʼs SAB procedure to identify HLA Class I antibodies. The resultant mean fluorescence intensity (MFI) data were compared by instrumentation, bead lot, and pretreatment regimens. Laboratory‐specific cutoffs for positive antibodies were applied to the results. RESULTS Interlaboratory variability for MFI values appears to be associated with different pretreatment regimens. The coefficient of variation (CV) of MFI from samples pretreated with ethylenediaminetetraacetic acid, dithiothreitol, or heat inactivation (EDHI) were similar, ranging from 14% to 56% (mean, 22%). For samples with no pretreatment, the CVs were significantly higher than EDHI‐treated samples, ranging from 25% to 74% (mean, 39%; 95% confidence interval, 12.10‐21.90; p < 0.0001). An intralaboratory comparison of pretreatment regimens confirmed these findings. Some positive antibody specificities present in EDHI‐treated samples were negative in corresponding samples with no pretreatment when laboratory‐specific cutoffs for positive antibodies were applied. CONCLUSION Our results show that greater interlaboratory precision can be achieved when samples are pretreated with EDHI as opposed to no pretreatment, likely because these pretreatments eliminate interference from inhibitors. Inhibitors may mask antibodies, leading to missed (or uncalled) specificities when no pretreatment is used.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1132
1537-2995
DOI:10.1111/trf.15666